3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
4
Brain Neoplasms
4
Pancreatic Neoplasms
3
Glioblastoma
3
Sarcoma
2
Neoplasms
2
Lung Neoplasms
2
Gliosarcoma
2
Glioma
2
Urothelial Carcinoma of the Bladder
1
Thoracic Neoplasms
1
Stage IA-IIA Breast Cancer
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Resected Pancreatic Adenocarcinoma
1
Recurrence
1
Pinealoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Gastrointestinal Neoplasms
1
Eye Neoplasms
1
Esophageal Neoplasms
1
Ependymoma
1
Desmoplastic Small Round Cell Tumor
1
Chordoma
1
Chondrosarcoma
1
Interventions
Gemcitabine
14
Cisplatin
13
Capecitabine
11
Oxaliplatin
9
Fluorouracil
9
130-nm albumin-bound paclitaxel
9
Paclitaxel
8
pembrolizumab
7
Ramucirumab
6
Leucovorin
6
Carboplatin
6
Bevacizumab
6
Albumin-Bound Paclitaxel
6
Pemetrexed
4
Nivolumab
4
Irinotecan
4
Everolimus
4
Erlotinib Hydrochloride
4
Docetaxel
4
Cyclophosphamide
4
trastuzumab deruxtecan
3
Radiotherapy
3
Afatinib
3
zolbetuximab
2
pralsetinib
2
cabozantinib
2
Trastuzumab
2
Ipilimumab
2
vosaroxin
1
vandetanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Adenocarcinoma
×
Proton Therapy
×
Clear all
No trials found.